Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.640
+0.170 (11.56%)
Apr 30, 2026, 4:00 PM EDT - Market closed
Estrella Immunopharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+387.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +387.80% | Feb 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 → $8 | Strong Buy | Maintains | $16 → $8 | +387.80% | Jan 28, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +875.61% | Nov 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +875.61% | Aug 12, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +875.61% | Jun 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +875.61% | May 29, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +875.61% | Feb 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +875.61% | Feb 18, 2025 |